Testicular cancer and Hodgkin's disease: evaluation of semen quality.

@article{Gandini2003TesticularCA,
  title={Testicular cancer and Hodgkin's disease: evaluation of semen quality.},
  author={Loredana Gandini and Francesco Lombardo and Pietro Salacone and Donatella Paoli and Anna Paola Anselmo and Franco Culasso and Franco Dondero and Andrea Lenzi},
  journal={Human reproduction},
  year={2003},
  volume={18 4},
  pages={
          796-801
        }
}
BACKGROUND The aim of our study was to establish whether there is a difference in semen quality between patients with testicular cancer (TC) and Hodgkin's disease (HD). METHODS We evaluated 342 patients affected by TC (n = 232) or HD (n = 110) who cryobanked sperm before initiating chemo- or radiotherapy. All TC patients were evaluated approximately 1 month after orchidectomy. RESULTS A total of 14 patients were azoospermic or cryptozoospermic. In the TC group (n = 222) the mean of the… 

Figures and Tables from this paper

Semen analysis of subfertility caused by testicular carcinoma
TLDR
The causes of poor semen quality in cancer patients are not well-understood, but the patients with impaired spermatogenesis should have precise examination to find out the correct diagnosis of problem and preserve the fertility before any treatment.
Semen quality before and after gonadotoxic treatment.
TLDR
The type of cancer or disease, and the pre-treatment sperm concentrations were found to be the most significant factors governing post-treatment semen quality and recovery of spermatogenesis.
Spermatogenesis in Hodgkin's lymphoma patients: a retrospective study of semen quality before and after different chemotherapy regimens.
TLDR
The results from the HL patients studied pre- and post-therapy demonstrate that spermatogenesis recovery depends on the therapeutic regimen used, and 75% of HL patients are normozoospermic prior to treatment.
Effects of oncological treatments on semen quality in patients with testicular neoplasia or lymphoproliferative disorders.
TLDR
An overall increase in sperm concentration was recorded about 18 months after the end of cancer treatments in the majority of patients, even if it was not possible to predict the evolution of each single case 'a priori'.
Effect of Malignancy on Semen Parameters
TLDR
It was found that all examined types of cancer significantly impaired sperm quality parameters, and the median of most semen parameters of patients with cancer were still in the normal WHO range, their fifth percentile, represents men with a delayed time to pregnancy.
The semen quality of 1158 men with testicular cancer at the time of cryopreservation: results of the French National CECOS Network.
TLDR
Semen parameters were more severely impaired for stage III tumors, and when patients had a history of cryptorchidism or when they were less than 20 years of age, which highlights that seminomas alter sperm production more significantly than nonseminoma tumors and seem to preferentially impair spermatogenesis in tumor-bearing testes.
Do malignant diseases affect semen quality? Sperm parameters of men with cancers
TLDR
In testicular tumours and in Hodgkin lymphoma, a semen concentration statistically lower than in the fertile population, while in patients with other cancers, there is no difference with the healthy men, and no correlation between semen quality and disease stage is found.
Sperm quality before treatment in patients with early stage Hodgkin’s lymphoma enrolled in EORTC-GELA Lymphoma Group trials
TLDR
There was an association between sperm quality and the presence or absence of B-symptoms, in particular fever and night sweats, and with modern fertilization techniques, in most patients with early-stage Hodgkin’s lymphoma sperm quality before treatment is good enough for future fatherhood.
...
...

References

SHOWING 1-10 OF 47 REFERENCES
Semen analysis and cryoconservation before treatment in Hodgkin's disease.
TLDR
The low rate of success with cryopreserved semen in these cases suggests the need for a more careful design of non-toxic chemotherapy regimens in combined modality treatment.
Testicular dysfunction in Hodgkin's disease before and after treatment.
Testicular cancer and spermatogenesis.
TLDR
Due to modern assisted reproductive technologies and micromanipulation achievements, the lower yield of spermatozoa in severe cases is no longer a major obstacle to offering cryopreservation to patients with testicular cancer.
Impaired testicular function in patients with carcinoma-in-situ of the testis.
TLDR
Not only spermatogenesis but also Leydig cell function is impaired in testes with CIS, and this impairment could be due to common factors in the pathogenesis of germ cell neoplasm and testicular dysfunction.
Semen analysis in testicular cancer and Hodgkin's disease: pre- and post-treatment findings and implications for cryopreservation.
TLDR
Surprisingly, 24% of men receiving chemotherapy recovered sperm counts greater than 10 million per ml up to 3 years after therapy, and recovery was seen in 35% of 23 men with initially poor sperm counts, but in only 26% of 19 with good initial counts.
Fertility after chemotherapy for testicular germ cell cancers.
TLDR
Analysis of pre-CT sperm count together with details of planned treatment can be used to predict recovery of spermatogenesis following germ cell CT, with clear evidence for continued recovery beyond 1 year.
Male gonadal dysfunction in patients with Hodgkin's disease prior to treatment.
  • U. Rueffer, K. Breuer, V. Diehl
  • Medicine, Biology
    Annals of oncology : official journal of the European Society for Medical Oncology
  • 2001
TLDR
Assuming HD is the major initial cause for infertility efforts should be made to identify new non-gonadal toxic chemotherapies to be able to regain fertility after effective therapy.
Is routine pre-treatment cryopreservation of semen worthwhile in the management of patients with testicular cancer?
TLDR
Pre-treatment cryopreservation of semen may be psychologically useful in patients with newly diagnosed testicular cancer, but its clinical significance is doubtful.
Semen quality after treatment for testicular cancer.
TLDR
During the last 14 years repeated sperm cell analyses and serum hormone analysis were done regularly in patients with testicular cancer before and after treatment, and improvement of the exocrine gonadal function was regularly observed during the following 2-3 years.
...
...